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Abstract
Background: Mechanical ventilation (MV) is associated with diaphragm weakness, a phenomenon termed
ventilator-induced diaphragmatic dysfunction. Weaning should balance diaphragmatic loading as well as
prevention of overload after MV. The weaning methods pressure support ventilation (PSV) and spontaneous
breathing trials (SBT) lead to gradual or intermittent reloading of a weak diaphragm, respectively. This study
investigated which weaning method allows more efficient restoration of diaphragm homeostasis.
Methods: Rats (n = 8 per group) received 12 h of MV followed by either 12 h of pressure support ventilation (PSV)
or intermittent spontaneous breathing trials (SBT) and were compared to rats euthanized after 12 h MV (CMV) and
to acutely euthanized rats (CON). Force generation, activity of calpain-1 and caspase-3, oxidative stress, and markers
of protein synthesis (phosphorylated AKT to total AKT) were measured in the diaphragm.
Results: Reduction of diaphragmatic force caused by CMV compared to CON was worsened with PSV and SBT
(both p < 0.05 vs. CON and CMV). Both PSV and SBT reversed oxidative stress and calpain-1 activation caused by
CMV. Reduced pAKT/AKT was observed after CMV and both weaning procedures.
Conclusions: MV resulted in a loss of diaphragmatic contractility, which was aggravated in SBT and PSV despite
reversal of oxidative stress and proteolysis.
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diaphragmatic dysfunction, Weaning
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Background
Mechanical ventilation (MV) is a life preserving tech-
nique in all patients with acute respiratory failure or
need for deep sedation. During this period the dia-
phragm remains inactive and is hampered after several
hours of inactivity, referred to as ventilator-induced
diaphragmatic dysfunction (VIDD) [1, 2]. Generation of
mitochondrial reactive oxygen species (ROS) has been
revealed to play an essential role [3, 4], and is pre-
requisite for further degradation by proteases [5, 6],
autophagy [2], and the proteasome system [7]. In addition,
protein synthesis is hampered via the protein kinase B
(AKT) pathway [1, 8].
Weaning failure in patients remains a serious concern
and VIDD is suspected to play a key role in this process.
The question how fast the diaphragm recovers after oc-
currence of VIDD remains controversial [9–11]. These
studies suggest that diaphragm function recovery seems to
dependent on load and mutual prevention of overload.
These data further support the idea that balancing
between reloading and prevention of overload is the
central issue in weaning patients from the ventilator
[12]. Actually, two weaning methods are recommended
in recent guidelines, spontaneous breathing trial (SBT)
allowing intermittent but full diaphragm reloading or
pressure support ventilation (PSV) [13], causing gradual
reloading. It is, however, not known, which of these
recommended weaning modes would lead to the most
efficient diaphragm regaining in terms of cellular
homeostasis and force.
We hypothesized that diaphragm reloading with PSV
or hourly SBT after 12 h of MV would lead to a fast and
complete recovery of diaphragm contractile force and
cellular homeostasis.
Methods
The study protocol was approved by the ethics committee
(Landesamt für Natur, Umwelt und Verbraucherschutz
Nordrhein-Westfalen, Germany, Permit number: AZ
84–02.04.2011.A277).
Design
Healthy, 450 g, male Sprague–Dawley rats were tracheo-
tomised and submitted to mechanical ventilation for
12 h under pentobarbital anaesthesia (Babylog 3000,
Draeger, Luebeck, Germany). After this intervention, an-
imals were separated into 3 groups (n = 8 each). The first
group was euthanized after these initial 12 h (CMV).
The second group breathed spontaneously under pres-
sure support ventilation (PSV) for 12 h and the third
group underwent an intermittent spontaneous breathing
trial (SBT), consisting of 5 min spontaneous breathing
each hour followed by 55 min of controlled mandatory
ventilation. An acutely anaesthetized group served as
control (CON; n = 8). In respect of animal care and the
obvious time dependence of VIDD as shown in many
studies, we decided not to examine 24 h of CMV under
pentobarbital anaesthesia as an additional control [14, 15].
No muscle relaxant was applied in any group.
Experimental procedure
Anaesthesia was initiated by intraperitoneal injection of
60 mg Pentobarbital/kg of bodyweight and sustained by
i.v. administration. During weaning, pentobarbital infu-
sion was lowered to allow spontaneous breathing but
keep an appropriate level of sedation present to protect
the animals from stress.
The interventional groups were tracheotomised and a
pressure-controlled ventilation was applied using a re-
spiratory rate of 60 bpm, a positive end-expiratory pres-
sure of 3 cmH2O, a tidal volume of 6–7 ml/kg and I:E
ratio of 1:1 to maintain a PaO2 of 70–100 mmHg.
All animals were continuously monitored [11]. A catheter
was inserted into the oesophagus to measure oesophageal
pressure and detect insufficient diaphragm / ventilator
interaction. Every 3 h arterial blood samples were taken for
measurement of blood gases. After 12 h of MV, animals of
the SBT group were removed from the ventilator to breathe
spontaneously every hour for 5 min [8] during the 12 h
study period. After 12 h of MV, animals in the PSV group
were ventilated with pressure support ventilation. The trig-
ger level, which is a relative number in the ventilator to be
set between 1 and 10 in 0.1 increments, was set to allow an
evident triggering of each breath without inducing an auto-
trigger. The level was therefore raised from the lowest trig-
ger level until no auto-trigger occurred anymore, detected
as pressure drop in the oesophageal pressure. The inspira-
tory pressure was set at the same level as during CMV to
uphold normocarbia. This level was reduced hourly by 1
cmH2O. The level was adapted and increased when the
respiratory rate increased above 100 bpm or hypercarbia
occurred despite sufficient respiratory rate. The minimum
inspiratory pressure to be delivered was 5 cmH2O due to
ventilator pre-settings (Fig. 1).
Control group
In the CON group, the diaphragm was removed after
tracheostomy and a short ventilation period (maximally
5 min) to prevent hypercarbia.
Functional and histological measurements
At the end of the experimental period, a segment of the
costal diaphragm was removed and muscular force was
assessed in vitro using our established protocol [11].
Another strip was embedded and frozen in liquid butane
for histological assessment of muscle fibre dimensions as de-
scribed before [16]. Fibre cross-sectional areas were examined
using immunofluorescence microscopy (approximately 200
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fibres per animal) and analysed using the software ImageJ
(v1.46 k; National Institute of Health, Bethesda, MA) [17].
Analysis of diaphragmatic inflammation
To asses diaphragmatic leukocyte activity neutrophils,
ED1+ macrophages, and ED2+ macrophages were
analysed using our established immunohistochemistry
protocol [9]. Cell densities were expressed as the num-
ber of labelled cells per cubic millimetre.
Biochemical measurements
Western blotting
Total protein concentration was determined with the
Bradford method [18]. Proteins were separated on a
polyacrylamide gel (6 for proteolysis markers, 12 for pro-
tein oxidation and 10 % for others) and transferred onto
a polyvinyldifluoride membrane. Ponceau S staining was
used to ensure equal loading and proper transfer of the
proteins. Blots were incubated overnight at 4 °C with
appropriate primary antibody and subsequently with the
suitable secondary antibody. Proteins were visualized
with chemiluminescent Peroxidase Substrate (Sigma-
Aldrich, Bornem, Belgium) and analysed with the soft-
ware package (Bio 1D) of the imaging system (Photo print,
Vilber, France).
Oxidative stress
Total protein carbonyl levels in the diaphragm were
measured using the Oxyblot Protein Oxidation Detection
Kit (Chemicon, Temecula, CA) following manufacturer’s
instructions. The oxidative index was defined as ratio be-
tween densitometric values of the oxidized proteins and
the Ponceau S stained bands [19].
Diaphragmatic 4-hydroxynonenal (4HNE) was used as
an index of lipid peroxidation. Polyclonal anti-4-HNE
antibody (MAB32495, R&D Systems, Abingdon, UK)
was used as primary antibody and a polyclonal rabbit
anti-mouse (P0260, Dako, Heverlee, Belgium) as second-
ary. Data were expressed as a ratio between densitomet-
ric values of 4-HNE and Ponceau S.
Protein synthesis
To assess the mTOR pathway, the phosphorylated AKT
protein was first detected using a rabbit polyclonal primary
antibody against total AKT (Cell Signaling Technology,
Danvers, MA), and HRP-conjugated goat anti-rabbit
secondary antibody (Cell Signaling Technology, Danvers,
MA). After detection, the blot was stripped for detection of
total AKT (Cell Signaling Technology, Danvers, MA). The
data were expressed as the ratio between band intensity of
phosphorylated AKT (pAKT) to total AKT.
Proteolysis
Calpain and caspase-3 activities were measured indir-
ectly by assessing the breakdown products of α-II spec-
trin (FG6090–0100, Enzo Life Sciences, Antwerp,
Belgium), a specific substrate of calpain and caspase-3.
The cleavage product of intact α-II spectrin by calpain
gives band at 150 kDa and at 120 kDa when cleaved by
caspase-3 while intact α-II spectrin is detected at
Fig. 1 Breathing rates, duty cycles and inspiratory pressure support
in the PSV group. Values are expressed as means ± SD
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260 kDa when labelled using a secondary antibody
(polyclonal rabbit anti-mouse P0260, Dako, Heverlee,
Belgium). Calpain and caspase-3 activities are expressed
as the ratio between the densitometric values of their
breakdown products to the intact α-II spectrin [19].
Statistical analysis
All data were analysed in masked randomization. Popu-
lation distribution was assessed with the Kolmogorov-
Smirnov test. Normally distributed data were compared
using one-way analysis of variance (ANOVA) and for
the force frequency measurements using a two-way
repeated-measures ANOVA. If the group effect was
significant, a Tukey post-hoc test was used for pair-
wise comparisons between all groups. Otherwise a
Kruskal-Wallis test followed by a Dunn’s post-hoc
test, was used as indicated in the results section. Data
are shown as means ± SD or median ± SEM, when appro-
priate. All statistical tests are two-tailed, significance was
established at p < 0.05 (GraphPad Prism 6.0, La Jolla, CA).
Results
Physiological variables during the experiment
Arterial blood pressure was stable throughout the entire
experimental period. Blood pressures were 124 ± 22 mmHg
(CMV), 111 ± 13 mmHg (PSV) and 94 ± 12 mmHg (SBT)
before sacrifice. Data of blood gases and pH did not differ
between all groups and remained inside physiological
ranges (Table 1, Additional file 1). The trigger setting in
the PSV group allowed a nearly complete synchronisation
between animal breaths and the pressure support. With
decreasing pressure support, breathing frequency in-
creased in the animals (Fig. 1).
Diaphragm function
The diaphragm force frequency curve was shifted down-
wards significantly at all stimulation frequencies in the
PSV and SBT groups compared to CON and CMV
(Fig. 2). The interaction between frequency and group
was significant (p < 0.0001), indicating significant differ-
ences between groups at all stimulation frequencies
(Fig. 2). The loss of diaphragm force in the PSV and SBT
groups compared to controls was similar (e.g. 160 Hz:
45 and 47 %, respectively).
Diaphragm histology
Histological planimetry of diaphragmatic fibre dimen-
sions did not show any significant differences in fibre
cross sectional areas for all groups compared to CON
(Table 2).
Diaphragmatic inflammation
Neutrophilic and macrophagic invasion were unaltered
as no significant differences in the quantity of neutro-
phils, ED1+, and ED2+ macrophages between all groups
were detected (Fig. 3).
Oxidative stress
Diaphragmatic 4-HNE levels were significantly increased
after CMV compared to PSV (+38 %, p = 0.034). There
were no differences in 4 HNE levels between PSV, SBT,
and CON (Fig. 4, panel a). Protein oxidation was signi-
ficantly increased by 42 % in the CMV compared to
others (vs. PSV p = 0.004; vs. SBT p = 0.007 and vs. CON
p = 0.047) (Fig. 4, panel b) but was similar to CON levels
in the PSV and SBT groups.
Markers of protein synthesis
Compared to CON, pAKT/AKT ratio was decreased to
a similar extent after CMV (−59, p = 0.06), SBT (−46,
p = 0.06), and PSV (−54 %, p = 0.1) but this reduction
failed to reach statistical significance (Fig. 5).
Proteolysis
Calpain activity was significantly elevated in CMV (+95 %,
p = 0.02) compared to CON and PSV while it was similar
to CON levels in the PSV and SBT groups (Fig. 6, panel a).
For caspase-3 activity no significant differences were
found between the groups (Fig. 6, panel b).
Discussion
Overview over principle findings
This is to our knowledge the first study examining the
impact of weaning methods PSV and SBT on diaphragm
function and metabolism after the onset of VIDD. Our
data show that both strategies further reduced diaphragm
force despite the fact that they reversed oxidative stress
and proteolysis caused by mechanical ventilation.
These findings are discussed in detail below.
Weaning using SBT and PSV does not result in diaphragm
function recovery
In the current study, neither SBT nor PSV applied as
weaning strategies after 12 h of CMV were associated
with diaphragm function recovery. In fact, each strategy
led to a worsening of diaphragm function and intriguingly
the magnitude of this attenuation was similar whether the
diaphragm was gradually (PSV) or intermittently fully
(SBT) reloaded. Our data are surprising in the context of
Table 1 Blood gases of the four groups at the end of the
experiment. Values are means ± SD
CON CMV PSV SBT
paO2 (mmHg) 91 ± 21 112 ± 19 104 ± 13 111 ± 16
paCO2 (mmHg) 38 ± 9 37 ± 8 37 ± 13 35 ± 9
pH 7.41 ± 0.05 7.47 ± 0.07 7.38 ± 0.07 7.45 ± 0.08
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previous studies, which demonstrated a rapid regaining in
diaphragm force within 4–7 to 24 h after induction of
VIDD, when the animals breathed completely independ-
ent from further assistance but with the risk of muscle
overload and inflammatory damage [9, 11]. Importantly,
in the PSV group the inspiratory pressure delivered by the
ventilator was decreased, i.e. the diaphragm had to
contract more forcefully; obviously, the increase of work
was not sufficient to regain force.
Although 5 min of spontaneous breathing seem to
protect, at least partially from a contractile deficit [8], it
is obviously not enough to regain muscle force. Martin
and colleagues proposed in patients an inspiratory
muscle training of very low duty cycles (i.e. 40 breaths
per day), resulting in a better patient inspiratory force
[20]. From our data we cannot support these findings
that a low duty cycle might be enough to regain muscle
force.
Theoretically, this decline in force could be induced by
overload; nevertheless the triggering was carefully set in
the PSV mode and airway obstruction during the 5 min
SBT phases were avoided.
SBT and PSV reverse diaphragmatic oxidative stress
MV resulted in an increase in oxidized proteins and lipid
peroxidation making sarcomeres more susceptible for
the breakdown by the protease system [6]. This find-
ing is in line with former publications from our groups
[6, 11, 21], defining it as one major pathway of VIDD [22].
Fig. 2 Force frequency relationship of the diaphragm in vitro. The weaning groups show a significant decrease in contractile force at all
stimulation frequencies compared to CON and CMV. a indicates p < 0.05 SBT vs. CON, p < 0.01 PSV vs. CON and PSV/SBT vs CMV; b indicates
p < 0.0001 PSV/SBT vs. CON, PSV vs. CMV and p < 0.001 SBT vs. CMV; c and d indicate p < 0.0001 PSV/SBT vs. CON and CMV; e and f indicate
p < 0.0001 PSV/SBT vs. CON and p < 0.001 PSV/SBT vs. CMV. Values are shown as means and SD
Table 2 Diaphragmatic cross sectional areas (in μm2) of type I,
IIA and IIx/b fibres for CON (n = 8), CMV (n = 8), PSV (n = 7) and
SBT (n = 7). Values are means ± S
Type I Type IIa Type IIx/b
CON
1838 ± 223 1886 ± 273 4445 ± 971
PSV
1693 ± 276 1847 ± 249 3978 ± 1264
CMV
1838 ± 294 1823 ± 454 4000 ± 835
SBT
1788 ± 320 1830 ± 389 4466 ± 1172
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The reduction in oxidative damage during the weaning
process might result in less cleavage of sarcomeric
proteins.
Both weaning strategies were able to reverse the
amount of oxidized proteins and lipid peroxidation but
this did not result in diaphragmatic functional improve-
ment. Muscle force depends on the number of myosin
heads forming parallel cross bridges per half sarcomere,
the steady state fraction of strongly bound cross bridges
in the force generating state and the force generated by
cross bridges [23]. Mitochondrial uncoupling may be re-
duced by activation of any kind as in our model and re-
sult in decreased oxidative damage of cellular structures
[23], but this had no impact on force generation.
Weaning reverses the activation of the calpain system
Mechanical ventilation induced an elevation of calpain
activity compared to CON in line with former publica-
tions from our group and others [24, 25]. The increase
in calpain activity was significantly down regulated after
weaning by PSV compared to CMV, but not in SBT
group. Previous studies examining diaphragmatic recov-
ery after MV reported various effects on these proteases
after reloading [5, 26, 27]. Thus, full diaphragm reload-
ing after extubation resulted in a complete reversal
towards control levels of both proteases calpain and
caspase-3 after 12 h of reloading and this was associated
with normalization of diaphragm function [11]. By
contrast, Thomas and colleagues did not observe any
Fig. 3 Diaphragmatic leukocyte activity measured as neutrophils
panel a, ED1+ macrophages panel b, and ED2+ macrophages panel
c. Cell densities were expressed as the number of labelled cells per
cubic millimetre. Values are means ± SD
Fig. 4 Levels of lipid peroxidation expressed as a ratio between
densitometric values of 4-HNE and Ponceau S (panel a) and oxidized
proteins as a ratio between densitometric values of the oxidized
proteins and Ponceau S (panel b) measured in the diaphragm after
only 12 h of CMV (CMV) or 12 h CMV and additional 12 h of weaning
(PSV, SBT) compared to CON. * p < 0.05 CMV vs. PSV (panel a) and
CMV vs. other groups (panel b). Values are means ± SD. IDV: Integrated
Density Value
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amelioration of protease activity after 4–7 h of diaphrag-
matic reloading [9], although animals in their study did
most likely have less diaphragm reloading due to sed-
ation and diaphragm fully recovered normal function.
This suggests that the calpain system restoration is not
only time dependent but also requires a certain amount
of reloading to normalize. In addition, these observations
also underline that the down regulation of these prote-
ases is not required for diaphragm force to recover.
We could not detect changes in macrophagic or neu-
trophilic invasion between the groups in contrast to
Thomas and colleagues. Possibly, different degrees of
reloading cause subsequently different inflammatory
responses.
Weaning did not alter the decrease in protein synthesis
As one major upstream between gaining of proteins
(protein synthesis) and proteolysis acts AKT. It increases
protein synthesis in the phosphorylated state and, while
dephosphorylated, AKT can induce the autophagy path-
way via mammalian target of Rapamycin [28, 29]. In the
current study, a decrease of pAKT/AKT was observed
during mechanical ventilation, comparable to former
studies [28]. This ratio remained reduced after both
weaning periods, indicating that protein synthesis was
still impaired with diaphragm reloading regardless of the
load applied to the diaphragm. It is therefore unlikely
that it contributed to the worsening of diaphragm func-
tion seen after weaning.
Model validation
Gradual reloading is used to protect the muscle from
overload-induced damage and to increase diaphragmatic
reloading while reducing inspiratory pressure support
[30]. We designed the PSV group closely to clinical
needs while beginning with support-level identical to the
inspiratory pressure during MV, gradual reduction, and
adaption based on respiratory physiology [13]. By de-
creasing pressure support, we surely induced an increase
in diaphragmatic activation. We re-increased the pres-
sure level during PSV when the respiratory rate in-
creased above 100 and/or hypercapnia occurred. It was
impossible in this model due to the ventilator type to
measure exact tidal volumes to calculate Vt/RR quotient
or assess distress as this can be done in awake patients
breathing through a tracheal cannula. Therefore our ap-
proach to guide the PSV setting was close to but not
exactly mimicking the clinical situation during the wean-
ing process. Nevertheless, even if the ventilator is set in
the best clinical practice in patients undergoing pressure
support ventilation, over-assistance in the clinical setting
may be apparent [31]. Over-assistance may be most likely
the reason for the worsening of diaphragm function in our
study.
Fig. 5 Diaphragm levels of activated AKT expressed as the ratio of pAKT/AKT in the different groups. Values are mean ± SD
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The frequency and duration of the spontaneous
breathing trials was chosen closely to the work of
Gayan-Ramirez and others, demonstrating preservation
from VIDD even by these short terms of interruption
from mechanical ventilation [8]. However, even in the
beginning of a weaning process, short trials of max
5 min several times a day may be used to initiate wean-
ing from the ventilator. It is important to notice that our
approach to implement hourly spontaneous breathing
intervals was based on scientific reasons by Gayan-
Ramirez and colleagues demonstrating preservation of
myogenic signalling using this strategy (see above) [8]
and cannot mimic the clinical scenario of a usually
30 min lasting first spontaneous breathing trial that is
prolonged in the following weaning attempts [32].
Limitations of the model and clinical impact
We chose our established rat model to investigate the
effects of different reloading approaches after MV, those
are appropriate for the animal model but differ from
those used in clinical practice. There is, however, evi-
dence that the same pathways are activated in rats and
humans and therefore findings in these animal models
can be transferred to humans [33, 34]. However, our
model is the first to describe biological effects of gradual
vs. intermittent reloading on the diaphragm, which is
not proven in humans, yet.
Over-assistance during PSV and due to the spontan-
eous breathing trial duration might have influenced
these results. Hudson and colleagues revealed that over-
assistance in pressure support ventilation cannot prevent
from VIDD [35] and could not reproduce the findings of
Futier and colleagues that demonstrated preservation of
diaphragm metabolism by pressure support ventilation
[36]. The actual load might therefore be essential for the
effects on diaphragm function. Nevertheless, prevention,
i.e. remaining sufficient load is different than regaining
of force as in our model.
Additionally we have to address the influence of the
sedative on the respiratory effort. Vaschetto and colleagues
impressively demonstrated that the breathing effort during
pressure support ventilation is dose-dependent of the
sedative agent [37]. Our animals were sedated keeping
them in a state of low sedation that suppressed moving
and vegetative disturbance. However we could not moni-
tor or titrate this sedation compared to the mentioned
study [37].
We decided not to add another control group of 24 h
of mechanical ventilation. Studying the rats under mech-
anical ventilation after 24 h of mechanical ventilation to
address, whether weaning would improve the loss of
diaphragm force caused by 12 h mechanical ventilation,
may not be fully suitable. Indeed, after 12 h of mechan-
ical ventilation, diaphragm force is reduced and we
wanted to know which weaning approach would lead to
more efficient restoration of diaphragm function, when
weaning the rats at this time point.
Additionally, the weaning period of 12 h was chosen
after the discrepant results from our study [11] and
Thomas et al. [9] study, which have been described
above. In our study investigating recovery with full dia-
phragm load [11], we have explained that the on-going
decline in contractile force after 12 h of full load might
have been due to overload that would be absent in a
gradual reloading as the one chosen in the actual work.
The decline in force despite loading is from our perspec-
tive due to insufficient loading.
Fig. 6 Indirect assessment of calpain activity (panel a) and caspase-3
activity (panel b) in the different groups. 120 kDa/260 kDa and
150 kDa/260 kDa represent the ratio of breakdown product to intact
αII-spectrin induced by calpain and caspase-3, respectively. Values
are mean ± SD. *p < 0.05 vs. CON and PSV. Values are expressed
as means ± SD
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Additionally protease activation, removal of oxidized
proteins and restoration of function may also be influ-
enced by time; reduction of protease action may be a
first step to re-balance cellular homeostasis, but con-
tractile force needs intact –replaced- sarcomeres to act.
Therefore our results can only be interpreted in the in-
vestigated time frame of unloading and reloading.
Does this study help to understand what happens in
weaning patients? At first, patients are weaned in more
than 12 h and even severely ill individuals can get weaned.
Importantly, our data indicate that the amount of load is
decisive for weaning success.
Conclusions
Pressure support ventilation with support levels that may
replace diaphragmatic work completely is insufficient to
regain force, and even short durations of SBT have the
same effect. Continuous clinical assessment according to
the guidelines of patients undergoing spontaneous breath-
ing trials is therefore of high importance. The guidance by
trans-diaphragmatic pressure monitoring or assessment of
diaphragmatic electric activity might be able to guide
weaning individually.
Additional file
Additional file 1: Figure S1. Arterial blood gas data in the CMV, PSV
and SBT groups. Values are expressed as means ± SD. (JPG 717 kb)
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